Some fertility problems announce themselves loudly. Absent periods, severe pain, a semen analysis that flags immediately. Others are quieter. A luteal phase defect is one of the quieter ones. Cycles may look regular on the surface. Ovulation is happening. The period arrives, perhaps a little early, perhaps preceded by spotting that starts a few days before the actual flow. And the attempts to conceive keep not working, without an obvious explanation.
The luteal phase is the second half of the menstrual cycle, the period between ovulation and the start of the next period. It doesn’t get nearly as much attention as the follicular phase or ovulation itself, but what happens during those days determines whether a fertilised egg has any chance of implanting and being supported through the earliest days of pregnancy.
What the luteal phase is actually doing
The hormonal shift after ovulation
After ovulation, the follicle that released the egg transforms into a temporary structure called the corpus luteum. Its job is to produce progesterone. Progesterone is what drives the luteal phase, preparing the endometrium for implantation and, if pregnancy occurs, supporting its early development until the placenta takes over around weeks 8 to 10.
Why progesterone timing matters
Progesterone causes the endometrial lining to become secretory, thickening and changing its cellular characteristics in a way that makes it receptive to an implanting embryo. It also suppresses uterine contractions and modulates the immune environment at the implantation site. Without adequate progesterone, for long enough, the lining doesn’t fully prepare, implantation is impaired, and the period arrives before an embryo has had time to establish.
What normal looks like
A normal luteal phase runs between 11 and 17 days, with most women falling between 12 and 14 days. It ends when progesterone levels drop sufficiently to trigger menstruation. The luteal phase length is relatively consistent within an individual, which is why women who track their cycles carefully sometimes notice a pattern of short second halves before they’ve identified it as a clinical issue.
When the luteal phase becomes a problem
The short luteal phase
A luteal phase below 10 days is generally considered short and potentially clinically significant. Below 9 days is where most clinicians would actively investigate. The short luteal phase symptoms are not always dramatic: periods that arrive a few days earlier than expected, spotting that begins 3 to 5 days before the period proper, sometimes premenstrual symptoms that come on unusually early.
The progesterone insufficiency picture
A luteal phase can be the right length in days but still be inadequate if progesterone production by the corpus luteum is insufficient, or if the endometrium doesn’t respond normally to the progesterone being produced. These are sometimes distinguished in clinical discussions as inadequate luteal phase versus luteal phase defect proper, though in practice the distinction is not always cleanly made.
The diagnostic challenge
Here is where it gets complicated, and where the clinical debate around this condition lives. Luteal phase defect doesn’t have a clean, universally agreed diagnostic standard. Progesterone levels in the luteal phase fluctuate considerably, even within the same cycle. A single mid-luteal progesterone measurement can miss the pattern. Endometrial biopsy, once used to assess the histological appearance of the lining in the luteal phase, is no longer considered a reliable diagnostic tool for this condition. Cycle tracking over multiple cycles, combined with timed progesterone measurements and clinical history, gives a more useful picture than any single test, though how extensively to investigate this depends on the individual clinical picture and your specialist’s judgement.
Why this gets missed or misdiagnosed
The “normal” cycle that isn’t quite
One thing that tends to happen with luteal phase issues is that they hide behind cycles that look regular when written on a calendar. If periods come every 25 to 27 days, that may seem normal. But if ovulation is occurring on day 14 or 15, and the period is arriving on day 25, the luteal phase is only 10 to 11 days, which is borderline at best. Nobody looks at that cycle chart and immediately flags a problem.
The spotting question
Spotting before a period is one of the more commonly reported short luteal phase symptoms, and it often gets explained away as normal variation or attributed to other causes. In some cases it is normal variation. In others, it reflects the progesterone drop that comes too early, and the endometrium beginning to break down before the cycle should end. Whether spotting in a particular person is significant requires context: how many days before the period, how consistently, and what the full hormonal picture looks like.
The connection to unexplained infertility
Luteal phase defect is one of the potential contributors to unexplained infertility that standard workups don’t always detect, because standard workups don’t typically include timed progesterone monitoring across multiple cycles. A single day-21 progesterone is taken as a proxy for ovulation confirmation, but it doesn’t tell you whether progesterone sustained adequately through the full luteal phase, or whether it peaked and dropped earlier than it should have.
What causes it
Upstream hormonal disruption
Luteal phase function depends on what happened earlier in the cycle. The corpus luteum forms from the follicle that ovulated, and the quality of the corpus luteum is influenced by how that follicle developed. Poor follicular development, driven by inadequate FSH or LH stimulation in the first half of the cycle, produces a corpus luteum that may not sustain adequate progesterone production.
Conditions that commonly underlie it
Several conditions are associated with luteal phase insufficiency. Hyperprolactinaemia, elevated prolactin, is one of the more common. Prolactin suppresses GnRH, which affects LH pulsatility, which in turn affects corpus luteum function. Thyroid dysfunction, particularly elevated TSH, is another. PCOS, where the follicular phase is dysregulated, can produce a corpus luteum that doesn’t sustain well. Low body weight and high-intensity athletic training, where the hypothalamic-pituitary axis is suppressed, are associated with shorter and less robust luteal phases.
Age and ovarian reserve
Diminished ovarian reserve, as ovarian function declines with age, is associated with shorter and less robust luteal phases. The corpus luteum’s capacity to produce progesterone is related to the quality of the follicle that preceded it, and that quality is affected by age and reserve.
Idiopathic cases
In some women, no underlying cause is identified. The luteal phase is consistently short or progesterone consistently insufficient without a clear hormonal or structural explanation. These cases are treated symptomatically.
Treatment: what actually helps
Progesterone supplementation
The most direct treatment for luteal phase deficiency is progesterone supplementation starting shortly after confirmed ovulation. This supports the endometrium through the implantation window regardless of what the corpus luteum is producing. Progesterone can be given vaginally (pessaries or gel), orally, or as intramuscular injection. Vaginal progesterone exploits the uterine first-pass effect, where absorption from the vaginal mucosa delivers higher concentrations to the uterine tissue than equivalent systemic dosing would achieve, which is why vaginal and injectable routes are more commonly used in fertility treatment than oral.
How long to continue
If pregnancy doesn’t occur, supplementation stops and the period follows. If a positive pregnancy test is obtained, progesterone is typically continued through the first trimester until the placenta takes over production, usually around 10 to 12 weeks.
Treating the underlying cause
Where a specific cause is identified, treating it is the more logical approach. Elevated prolactin responds to dopamine agonists like cabergoline, which lower prolactin and allow normal LH pulsatility and corpus luteum function to resume. Thyroid dysfunction, as discussed elsewhere in this series, should be optimised before fertility treatment. In PCOS, ovulation induction or IVF may address follicular development issues that are producing poor corpus luteum function downstream.
Ovulation induction
In some cases, using clomiphene or letrozole to stimulate follicular development produces better quality follicles and subsequently better corpus luteum function. This approach addresses the upstream issue rather than just supplementing the downstream deficiency.
Luteal phase defect and IVF
Why it’s less of a concern in IVF cycles
Luteal phase defect and IVF have a specific relationship: in IVF, the luteal phase is almost universally supported with exogenous progesterone from the day of egg retrieval or embryo transfer, regardless of whether the patient has a known luteal phase issue. This is because the egg retrieval process removes granulosa cells from the follicles, which affects corpus luteum formation and reduces natural progesterone production. Everyone having IVF gets progesterone support.
When it’s still relevant
The clinical question of luteal phase quality becomes more relevant in natural cycle monitoring, in IUI cycles where stimulation is mild, and in the context of investigating recurrent implantation failure. If a patient has had multiple failed transfers despite good embryo quality and adequate endometrial thickness, and nobody has assessed the hormonal profile of the luteal phase in detail, that’s a gap worth discussing with a specialist.
Progesterone monitoring in IVF transfers
There’s growing interest in whether serum progesterone levels on the day of embryo transfer in medicated FET cycles can affect outcomes. Some studies have found that low serum progesterone at transfer, even with standard vaginal supplementation, is associated with lower implantation and pregnancy rates. Some clinics now measure progesterone on transfer day and adjust supplementation if levels fall below a target threshold. The evidence here is still evolving and practice is not uniform, but it represents a more individualised approach to progesterone management than a standard fixed-dose protocol.
Two hypothetical situations that show how this plays out
A 30-year-old who has been tracking her cycles carefully for eight months without conceiving. Ovulation consistently occurs around day 14 or 15. Her period arrives on day 24 or 25. The luteal phase is 9 to 10 days. She notices spotting for 2 to 3 days before her period arrives. Her standard fertility workup, which included a day-21 progesterone, came back with a level of 28 nmol/L. The GP said this confirmed ovulation. It did confirm ovulation. It didn’t confirm that progesterone sustained adequately through the full luteal phase. In a profile like this, a conversation with a fertility specialist about the pattern, including whether additional progesterone monitoring might be informative in her specific case, is a reasonable next step. If a consistent short luteal phase is confirmed clinically, luteal phase progesterone support is a low-risk, logical first intervention to discuss.
A different hypothetical: a 36-year-old with two failed frozen embryo transfers, both with confirmed euploid embryos, good endometrial thickness, and standard vaginal progesterone supplementation. Serum progesterone on transfer day was not checked in either cycle. Third cycle includes progesterone monitoring on the day of transfer. The level comes back at 8.9 ng/mL, below the 10 ng/mL threshold some clinics use as a target in medicated FET cycles. The protocol is adjusted to add injectable progesterone alongside the vaginal route. The third transfer results in a successful pregnancy. Whether the progesterone adjustment made the difference cannot be said with certainty, and this approach isn’t yet standard at every centre. But a gap in the monitoring was identified, addressed, and the outcome was different.
The part of the cycle nobody talks about enough
The luteal phase tends to sit in the background of fertility investigations. Tests focus on ovarian reserve, tubal patency, uterine structure, and semen quality. The functional hormonal quality of the second half of the cycle rarely gets the same attention, even though it’s where the critical events of implantation and early pregnancy support happen.
This isn’t an argument for investigating every patient with a luteal phase protocol from the start. But in women with unexplained infertility, short cycles, premenstrual spotting, or recurrent early pregnancy loss, the luteal phase is a reasonable and underused variable to raise with a specialist before adding more complex interventions.
Sometimes the answer is in the second half of the cycle, and it was just never looked at carefully enough.
Book a consultation at 9M Fertility.
→ Also read: Recurrent Miscarriage: Causes, Tests and When to See a Specialist
→ Also read: Unexplained Infertility: When Tests Are Normal but You Can’t Conceive
